Investing.com - Eli Lilly (NYSE: LLY ) Chief Executive Officer David Ricks said the company will test obesity drugs for smoking and alcohol abuse, according to Bloomberg.
Ricks added that the studies on addiction will start in 2025.
Investing.com - Eli Lilly (NYSE: LLY ) Chief Executive Officer David Ricks said the company will test obesity drugs for smoking and alcohol abuse, according to Bloomberg.
Ricks added that the studies on addiction will start in 2025.